Nektar Says Eli Lilly Botched Autoimmune Drug Trials

By Ayden Crosby · August 7, 2023, 7:47 PM EDT

Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Nektar Therapeutics v. Eli Lilly & Co

Case Number

3:23-cv-03943

Court

California Northern

Nature of Suit

Contract: Other

Date Filed

August 07, 2023

Featured Stories

Virta Health's Diabetes Mission Is Personal For Its GC No Photo Available

Michele Gorman

Jamie Anderson said it's important to find a mission-driven company to join — and when that mission aligns with an attorney's personal... (more story)

Healthcare Hires: Ex-DOJ, Fresenius Attys On The Move No Photo Available

Gianna Ferrarin

An ex-federal prosecutor who led healthcare fraud investigations in Texas has joined Hicks Thomas LLP, and an attorney with in-house e... (more story)

A Trump Do-Over On 'Most Favored Nation' Drug Prices No Photo Available

Yeji Jesse Lee

President Donald Trump's move this week to "equalize" U.S. drug prices with lower overseas prices hearkens back to a similar effort ma... (more story)